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Abstract 
Background: Acute kidney injury (AKI) occurs in up to 50% of all critically ill patients and hemodynamic abnormali-
ties are assumed to contribute, but their nature and share is still unclear. We explored the associations between 
hemodynamic variables, including cardiac index and right ventricular function, and the occurrence of AKI in critically 
ill patients.
Methods: In this prospective cohort study, we included all patients acutely admitted to an intensive care unit (ICU). 
Within 24 h after ICU admission clinical and hemodynamic variables were registered including ultrasonographic 
measurements of cardiac index and right ventricular function, assessed using tricuspid annular plane systolic excur-
sion (TAPSE) and right ventricular systolic excursion (RV S’). Maximum AKI stage was assessed according to the KDIGO 
criteria during the first 72 h after admission. Multivariable logistic regression modeling was used including both 
known predictors and univariable significant predictors of AKI. Secondary outcomes were days alive outside ICU and 
90-day mortality.
Results: A total of 622 patients were included, of which 338 patients (54%) had at least AKI stage 1 within 72 h after 
ICU admission. In the final multivariate model higher age (OR 1.01, 95% CI 1.00–1.03, for each year), higher weight (OR 
1.03 CI 1.02–1.04, for each kg), higher APACHE IV score (OR 1.02, CI 1.01–1.03, per point), lower mean arterial pressure 
(OR 1.02, CI 1.01–1.03, for each mmHg decrease) and lower TAPSE (OR 1.05, CI 1.02–1.09 per millimeter decrease) were 
all independent predictors for AKI in the final multivariate logistic regression model. Sepsis, cardiac index, RV S’ and 
use of vasopressors were not significantly associated with AKI in our data. AKI patients had fewer days alive outside of 
ICU, and their mortality rate was significantly higher than those without AKI.
Conclusions: In our cohort of acutely admitted ICU patients, the incidence of AKI was 54%. Hemodynamic variables 
were significantly different between patients with and without AKI. A worse right ventricle function was associated 
with AKI in the final model, whereas cardiac index was not.
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Background
Acute kidney injury (AKI) occurs in up to 50% of criti-
cally ill patients and is associated with increased mortal-
ity and morbidity [1–4]. Patients with more severe AKI 
have increased mortality rates and even when recovered 
remain at increased risk of unfavorable long-term out-
come [4–7]. No specific interventions to reverse AKI 
exist, and current guidelines make recommendations 
against most interventions that have been studied, sug-
gesting to limit fluid overload and to target mean arterial 
blood pressure at 65 mmHg to protect renal function [8, 
9].
A variety of pathophysiological mechanisms are 
hypothesized to be related to the development of AKI, 
but causal mechanisms remain largely unclear. Sepsis and 
hypovolemia are hypothesized to play a role, and both 
may result in inflammation and hypoperfusion [10, 11]. 
However, studies on kidney hypoperfusion suggest that 
reduced arterial blood flow is not the largest contribut-
ing hemodynamic factor for the development of AKI [10, 
12]. In patients with sepsis renal hyperperfusion may 
occur and inflammatory mechanisms may dominate in 
AKI [11]. Another factor suggested to be associated with 
development of AKI is liberal fluid therapy [13–16]. Flu-
ids may hypothetically induce venous congestion which 
may reduce renal blood flow and contribute to the occur-
rence of AKI [17]. Singular proxies of venous congestion 
such as fluid balance and central venous pressure (CVP) 
have been shown to be associated with AKI, but no defi-
nition for venous congestion exists [17, 18]. Venous con-
gestion as contributor to AKI might also explain why 
fluid resuscitation does not improve kidney function 
[13–15, 19].
One method to advance our understanding of this 
complex syndrome is to explore associations between 
AKI development and hemodynamic variables, including 
cardiac index and right ventricular function in acutely 
admitted critically ill patients. The objective of the cur-
rent sub-study was to evaluate the association of AKI 
with hemodynamic variables including critical care ultra-
sonography (CCUS) measurements of both the left and 
right ventricles. We hypothesized that decreased right 
ventricular function is associated with venous conges-
tion. Venous congestion may cause changes in venous 
outflow of the kidney, in addition to the arterial compo-
nent of kidney perfusion, and may be associated with the 
development and severity of AKI.
Methods
Design and setting
This is a sub-study of the Simple Intensive Care Stud-
ies I (SICS-I), a single-center, prospective observational 
study designed to evaluate the diagnostic and prognostic 
value of combinations of clinical and hemodynamic vari-
ables in critically ill patients (NCT02912624) [20, 21]. 
This sub-study, which we will from now on refer to as 
the current study, was implemented in the SICS-I on 
February 10, 2016. The local institutional review board 
(Medisch Ethische Toetsingscommissie of the Univer-
sity Medical Center Groningen; UMCG) approved the 
study (M15.168207). We report our study in adherence to 
STROBE guideline (Additional file 1: Table S1) [22].
Participants and study size
All acutely admitted patients of 18 years and older with 
an expected ICU stay of at least 24  h were eligible for 
inclusion. Exclusion criteria were discharge within 24  h 
and absence of informed consent. In the present study, 
we further excluded patients in which we were unable to 
obtain measurements of right ventricular function and 
patients with history of chronic kidney disease or dialysis 
prior to admission. Study size was dependent on patients 
included within SICS-I and amount of available data.
Variables
We registered patient characteristics at admission, 
including the APACHE IV scores and use of vasopres-
sors and/or inotropes according to our protocol [23]. 
Variables necessary for the diagnosis (and severity) of 
AKI were recorded up until 72  h after admission. The 
hemodynamic variables were measured once (within 
first 24  h of ICU admission) at the earliest possibility. 
We prospectively recorded data from physical examina-
tion, including heart rate, systolic blood pressures (SBP), 
diastolic blood pressures (DBP), central venous pressure 
(CVP), mean arterial pressure (MAP) and central tem-
perature. We recorded several CCUS variables (Vivid-S6, 
GE Healthcare, London, UK) including cardiac index, 
tricuspid annular plane systolic excursion (TAPSE) and 
right ventricular systolic excursion (RV S’). Cardiac index 
was estimated by the velocity time integral of left ventric-
ular outflow tract times heart rate times left ventricular 
outflow tract area (cardiac output = VTI × HR × LVOT 
area), divided by body surface area. All measurements 
were conducted by research-students, who were not 
involved in patient care. All researchers were trained 
by experienced cardiologist-intensivists to conduct a 
focused CCUS before contributing to the study. Train-
ing included studying of theory, practice on healthy indi-
viduals and lastly supervised CCUS in patients. The first 
20 examinations were supervised by a senior researcher. 
The images and measurements of cardiac index were vali-
dated and remeasured by an independent core laboratory 
(Groningen Image Core Lab, UMCG, Groningen, the 
Netherlands) for purposes of the main study.
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Definitions
We defined AKI and its severity according to the KDIGO 
criteria based on serum creatinine, urinary output 
recorded cumulative every 24 h and use of RRT [24]. The 
modification of diet in renal disease (MDRD) formula 
was used for estimation of the ideal serum creatinine for 
each individual as baseline assuming a creatinine clear-
ance of 75 ml/min/m2, as suggested by [25, 26]. Chronic 
kidney disease was defined by serum creatinine above 
177 µmol/L (following the definition used by the ‘Nation-
ale Intensive Care Evaluatie’) [27]. Cutoff values for car-
diac function were below 2.2  L/min/m2 for low cardiac 
index, below 17 mm for low TAPSE and below 9.5 cm/s 
as low RV S’ [28]. Patient outcome variables were the 
occurrence and maximum severity of AKI within the first 
72 h of ICU stay, number of days alive outside ICU and 
90-day mortality.
Bias
To assess selection bias we compared baseline character-
istics between included and excluded patients. We aimed 
to minimize possible misclassification bias by provid-
ing comprehensive protocols and training for involved 
researchers.
Statistics
The overall statistical methods were described in 
the pre-defined statistical analysis plan of SICS-I 
(NCT02912624). Continuous variables were reported as 
means [with standard deviations (SD)] or medians [with 
interquartile ranges (IQR)] depending on distribution. 
Categorical data were presented in proportions. Associa-
tions were calculated as odds ratios (OR) with 95% con-
fidence intervals (CI). Student’s T test, Mann–Whitney 
U test or the Chi-square tests were used as appropriate. 
A two-sided p value of ˂0.05 was considered statistically 
significant. Associations of hemodynamic variables with 
the occurrence of AKI were first explored by univariate 
analysis. We used univariate associations with p < 0.1 
for entrance of a variable into the multivariable model, 
while the predisposing variables age and sepsis were 
included in the model based on the literature, irrespec-
tive of their p values in the univariate analyses. No miss-
ing data were imputed, and a multivariate analysis was 
performed based on available original data, except for 
variables with more than 50% missing values, which were 
excluded from the model [23]. Variables were assessed 
for collinearity before entrance in the multivariable 
model. If two variables were strongly correlated, only one 
variable was included in the multivariate model based 
on the strongest univariate association. The final model 
was based on logistic regression analysis to identify the 
variables independently associated with the development 
of AKI. Discrimination (to distinguish AKI patients from 
non-AKI patients) of the final model was evaluated with 
receiver operating characteristic (ROC) curves. Calibra-
tion of the multivariable model (i.e., the number of AKI 
cases that the model predicts correctly across different 
risk groups) was checked with the Hosmer–Lemeshow 
test and by plotting observed AKI proportions against 
predicted risks of 10 equally sized groups. Analyses were 
performed using Stata, version 15 (StataCorp, College 
Station, TX, USA).
Results
Between March 27, 2015, and July 22, 2017, a total of 
1075 patients were included in the SICS-I study. The pre-
sent study started on February 10, 2016, and included 
897 patients. A total of 63 patients had a history of 
CKD or dialysis prior to ICU admission and were there-
fore excluded. In 212 patients, CCUS did not include 
right ventricular assessment, leaving 622 patients to be 
included (Fig. 1). Median time to inclusion was 14 (± 8) h 
after ICU admission. We evaluated the baseline char-
acteristics of the included patients and the 212 patients 
excluded due to missing values of right ventricle assess-
ment. There was significantly higher weight, lower per-
centage of diabetic patients, more use of vasopressors 
and percentage of mechanical ventilation in the excluded 
group; other baseline variables and APACHE IV score 
were similar (Additional file 1: Table S2).
Fig. 1 Study inclusion flowchart
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A total of 338 patients (54%) fulfilled the criteria for 
AKI within 72 h after admission, including 105 patients 
(17%) with AKI stage 1; 136 patients (22%) with AKI 
stage 2; and 97 patients (16%) with AKI stage 3, respec-
tively. One patient with AKI stage 1 could not be evalu-
ated for deterioration into AKI stage 2 or 3 due to early 
death. Several baseline characteristics of patients with 
and without AKI were different (Table  1). The mean 
observed cardiac index was 2.6 (± 0.9)  L/min/m2; mean 
TAPSE was 19.5 (± 6.1)  mm; and mean RV S’ was 13.5 
(± 4.1) cm/s. Low cardiac index, low TAPSE and low RV 
S’ were observed in 35%, 33% and 16% of patients, respec-
tively. Of the 338 patients with AKI, 61 patients had both 
low CI and low TAPSE, compared to 19 patients in the 
non-AKI group (p = 0.001). RRT was instigated in 32 
patients (5.1%) during their ICU stay. No loss to follow-
up occurred. Median days alive out of ICU at 90-day 
follow-up were 86.6  days (IQR 78.2–88.2) in patients 
without AKI and 83.5  days (IQR 3.0–87.4) in patients 
with AKI (p < 0.001). Of the 622 patients, 161 patients 
(26%) had died at 90-day follow-up. Mortality was 33% in 
the AKI group and 18% in the non-AKI group (p < 0.001). 
Associations with AKI
All hemodynamic variables were statistically significantly 
associated with AKI in the univariate analysis (Addi-
tional file 1: Table S3). CVP was missing in over 50% of 
cases (measured in only 112 patients) and thus was not 
included in the final multivariate model. Due to col-
linearity between MAP and systolic and diastolic blood 
pressures, we only included MAP in the model. No fur-
ther collinearity was observed. All remaining variables 
with p < 0.1 in univariate analysis were entered into the 
adjusted model.
In multivariate analysis, positive end-expiratory pres-
sure (PEEP), cardiac index, RV S’, vasopressors and cen-
tral temperature were shown to have a p > 0.1 and were 
removed from the model (p = 0.95, p = 0.71, p = 0.19, 
p = 0.17 and p = 0.10, respectively). In the final model 
heart rate was not significantly associated with AKI. 
Higher age, higher weight, increased APACHE IV scores, 
lower MAP and lower TAPSE were all statistically signifi-
cantly associated with AKI (Table 2). The receiver operat-
ing characteristic (ROC) curve of the final model yielded 
an area under the curve of 0.75 (95% CI 0.73–0.80), 
Table 1 Baseline and hemodynamic characteristics in the overall population and patients with and without AKI
SD standard deviation, PEEP positive end-expiratory pressure, RRT renal replacement therapy, CVP central venous pressure, RV S’ right ventricular systolic excursion, 
TAPSE tricuspid annular plane systolic excursion
*p value of difference between non-AKI and AKI patients
Total (n = 622) No AKI (n = 277) AKI (n = 376) p value *
Age, years (SD) 61 (15) 58 (16) 64 (14) < 0.001
Gender, n male (%) 385 (62%) 180 (63%) 205 (61%) 0.49
Height, cm (SD) 175.6 (9.5) 175.8 (9.9) 175.5 (9.1) 0.71
Weight, kg (SD) 81.6 (16.5) 77.9 (14.9) 84.7 (17.1) < 0.001
Diabetes mellitus, n (%) 129 (21%) 57 (20%) 72 (21%) 0.71
Liver cirrhosis, n (%) 21 (3.4%) 7 (2.5%) 14 (4.1%) 0.25
Mechanical ventilation, n (%) 357 (57%) 159 (56%) 198 (59%) 0.51
 PEEP, cm  H2O (IQR) 7.0 (5.0, 8.0) 6.0 (5.0, 8.0) 8.0 (5.0, 10.0) < 0.001
Sepsis, n (%) 100 (16%) 38 (13%) 62 (18%) 0.093
Use of vasopressors, n (%) 287 (46%) 108 (38%) 179 (53%) < 0.001
Use of RRT, n (%) 32 (5.1%) 0 (0.0%) 32 (9.5%) < 0.001
APACHE IV, mean (SD) 74.9 (28.9) 64.6 (23.4) 83.6 (30.2) < 0.001
Hemodynamic variables
Heart rate, bpm (SD) 84 (20) 81 (19) 87 (20) < 0.001
Mean arterial pressure, mmHg (SD) 79 (15) 83 (15) 77 (15) < 0.001
Systolic BP, mmHg (SD) 120 (26) 126 (26) 115 (24) < 0.001
Diastolic BP, mmHg (SD) 60 (12) 62 (11) 59 (12) 0.007
Cardiac index, L/min/m2 (SD) 2.7 (0.9) 2.8 (0.9) 2.6 (1.0) 0.026
Central temperature, °C (SD) 36.9 (0.9) 37.0 (0.9) 36.9 (0.9) 0.019
CVP, mmHg (SD) 9.1 (5.7) 7.3 (4.6) 10.1 (6.1) 0.015
RV S’, cm/s (SD) 13.5 (4.1) 14.1 (3.7) 13.1 (4.3) 0.002
TAPSE, mm (SD) 19.5 (6.1) 20.9 (5.5) 18.4 (6.4) < 0.001
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pseudo-R2 = 0.15. Hosmer–Lemeshow goodness-of-fit 
test showed a χ2 10.04; p = 0.2623.
A sensitivity analysis was performed with the final 
model and CVP in patients in which this was available 
(n = 94), which showed no statistically significant asso-
ciation for CVP (OR 1.08; 95% CI 0.99–1.20, p = 0.098) or 
lower TAPSE (OR 1.04; 95% CI 0.96–1.13, p = 0.252) with 
AKI (Table 3).
Discussion
In this prospective observational study, we found that 
lower MAP and lower TAPSE were both independently 
statistically significantly associated with the develop-
ment of AKI, along with higher age, higher weight and 
increased APACHE IV scores. Cardiac index was not 
independently statistically significantly associated with 
AKI.
Venous congestion and AKI
Singular proxies of venous hemodynamic function have 
previously been associated with the development of AKI 
[18, 29–33]. Chen et al. found that peripheral edema was 
associated with a 30% higher risk of AKI in 2238 criti-
cally ill patients. In the same article the authors showed 
that each cm  H2O higher CVP was associated with a 2% 
higher adjusted risk of AKI in 4761 critically ill patients 
[17]. We assessed right ventricular function measured by 
TAPSE and confirmed these observations of the potential 
role of central venous hemodynamic function, assum-
ing that venous congestion, with CVP as a proxy, leads 
to impaired right ventricular function, and vice versa. 
In the sensitivity analysis including CVP the point esti-
mates were similar, but in a relatively small sample size 
these effects did not reach statistical significance. Right 
ventricular function has also been suggested to be associ-
ated with the development of AKI by data from patients 
with heart failure by Mullens et  al. [34] and pulmonary 
hypertension by Haddad et  al. [35]. Guven et  al. [36] 
described that preoperative right ventricular function 
was associated with an increased risk and severity of AKI 
in 595 heart transplant patients. To our best knowledge, 
in no studies these measurements were performed pro-
spectively in an unselected population of the critically ill. 
We evaluated two measures of right ventricular function: 
TAPSE and RV S’. Huang et  al. [37] elegantly described 
that most studies use these as indices of RV function, but 
evaluation of isolated TAPSE is potentially misleading. 
Other indices of RV function or for example inferior vena 
cava measurements may also reflect venous congestion 
and be associated with AKI [38]. Fluid balance may influ-
ence right ventricular function and thus interact with 
the association with AKI [39]. The optimal variable rep-
resenting venous hemodynamic function for evaluation 
of association with AKI in the critically ill is to be eluci-
dated. A combination of previously mentioned variables 
might show a higher predictive value for venous conges-
tion and AKI in critically ill patients compared to TAPSE 
alone.
Arterial function and AKI
Only limited data specifically address the association 
between cardiac index and AKI. Many studies focus on 
the association between (septic) shock and AKI [40, 41], 
while data on the detailed association between cardiac 
index, MAP and renal blood flow in critically ill patients 
in general and AKI are sparse [42, 43]. In a retrospective 
cohort study of 1879 critically ill patients, both impaired 
left and right ventricular function were associated with 
AKI and increased mortality [44]. One study included 
10 patients with sepsis and AKI and suggested that the 
renal perfusion fraction of cardiac output measured by 
phase contrast magnetic resonance imaging was very low 
(7.1%) [45]. One hypothesis is that AKI develops after 
ischemic and hypoxic damage due to restricted blood 
flow, possibly caused or exaggerated by a reduced cardiac 
index. A higher cardiac index may be protective for AKI, 
or reverse, that a low cardiac index would be associated 
with increased incidences of AKI, although other mecha-
nisms may be involved. We found no association between 
cardiac index and AKI, while a lower MAP appeared to 
Table 2 Variables independently associated with  the   
development of AKI in multivariable analysis
Description: pseudo-R2 = 0.15. Hosmer–Lemeshow goodness-of-fit test χ2 10.04; 
p = 0.2623. AUC = 0.75 (95% CI 0.73–0.80). APACHE acute physiology and chronic 
health evaluation; TAPSE tricuspid annular plane systolic excursion
OR 95% CI p value
Age (per year increase) 1.01 1.00 1.03 0.038
Weight (per kg increase) 1.03 1.02 1.04 0.000
APACHE IV (per point increase) 1.02 1.01 1.03 0.000
Mean arterial pressure (per 
mmHg decrease)
1.02 1.01 1.03 0.001
TAPSE (per mm decrease) 1.05 1.02 1.08 0.002
Table 3 Sensitivity analysis with  central venous pressure 
in the multivariate model (n = 94)
OR 95% CI p value
Age (per year increase) 1.00 0.96 1.04 0.898
Weight (per kg increase) 1.04 1.01 1.07 0.006
APACHE IV (per point increase) 1.02 1.00 1.04 0.049
Mean arterial pressure (per 
mmHg decrease)
1.01 0.96 1.05 0.659
TAPSE (per mm decrease) 1.05 0.96 1.12 0.252
CVP (per mmHg increase) 1.08 0.98 1.18 0.098
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be associated with AKI. Findings from a previous pro-
spective observational study evaluating associations 
between hemodynamic variables and the progression 
of AKI in septic patients suggested that a lower MAP is 
associated with AKI [40].
Similar to other studies, higher PEEP showed associa-
tion with AKI; however, in the multivariate model PEEP 
did not remain significant [46, 47]. The fact that PEEP in 
this study did not contribute enough to the final model 
might be explained by the relatively low PEEP levels and 
the regularly used lower tidal volumes (for the purposes 
of lung-protective ventilation) leading to substantial 
lower intrathoracic pressures compared with the men-
tioned studies. Moreover, only 57% of our population was 
mechanically ventilated, potentially leading to a bias in 
our multivariate analysis in terms of this variable, and we 
did not evaluate other ventilation settings such as plateau 
pressure.
Implications and generalizability
We conducted a single-center study. Collaboration with 
other centers and other ICUs will increase generalizabil-
ity. We included a broad population of acutely admitted 
critically ill patients, while investigation of hemodynamic 
variables in subgroups might yield more specific clues of 
the role of hemodynamic variables in the pathophysiol-
ogy of AKI according to diagnosis, e.g., sepsis or shock 
patients. Our observations encourage to elaborate spe-
cifically on the role of venous hemodynamic function 
in the development of AKI and to search for a practical 
proxy, or perhaps a combination of multiple variables, for 
assessment of venous congestion. This is also in line with 
the recently proposed research agenda for AKI [48].
Limitations
Several limitations of our study must be acknowledged. 
First, our study is a prospective observational study, 
which hampers causal inferences. As it is a data-driven 
analysis, results need to be confirmed in other studies. 
Second, we collected kidney function up to 72  h, i.e., 
early AKI. Therefore, the incidence and severity of AKI 
may both have deteriorated or improved after 72 h. It has 
been suggested that the incidence of AKI is highest dur-
ing the initial days of ICU stay [49], although continued 
fluid administration during or after early AKI might pre-
vent recovery of kidney function [50]. Variables identi-
fied as associated with AKI might vary with the timing 
of assessment of variables and diagnosing AKI [51], so 
that longer follow-up will probably lead to identification 
of another set of variables associated with AKI. Third, 
CVP was measured in fewer patients and had to be 
excluded from multivariate analysis in this cohort. This 
is an important limitation, as CVP may serve as one of 
the proxies for venous congestion and right ventricular 
function. This, however, does not influence the conclu-
sion that TAPSE was associated with AKI, whereas car-
diac index was not. Fourth, we used the MDRD formula 
to estimate baseline serum creatinine since these data 
were not collected in the main study. Even though this 
method is widely accepted, this might have led to either 
an over- or underestimation of AKI incidence [52, 53]. 
Fifth, we used serum creatinine as a marker of kidney 
function. Despite recent observations on the accuracy of 
serum creatinine [26], serum creatinine is still a surro-
gate for kidney function. Also, creatinine might be biased 
by interventions during ICU stay, such as hemodilution 
due to a positive fluid balance. Last, 21% of the patients 
were excluded from analyses due to inadequate quality 
of CCUS images which may be difficult to obtain in ICU 
patients [54]. Weight and mechanical ventilation were 
significantly different in this group, which are factors that 
often hamper transthoracic CCUS. The use of vasopres-
sors was also more prevalent in the excluded group, but 
as APACHE IV score was not significantly different, we 
assumed that the groups were similar. We thus do not 
expect that this has influenced the findings of this study.
Conclusions
In acutely admitted ICU patients decreased right ven-
tricular systolic function and MAP, but not cardiac index, 
were associated with the development of AKI. Further 
research elaborating on right heart function in combina-
tion with other proxies for venous congestion may eluci-
date its role in the development or worsening of AKI in 
the critically ill.
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